Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001779934-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 11, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
23,250
Total Value
$941,822.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 10, 2026 | Exercise/Conversion | 1,250 | $19.36 | $24,200.00 | 1,250 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Exercise/Conversion | 6,500 | $11.20 | $72,800.00 | 7,750 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 1,450 | $107.58 | $155,991.00 | 6,300 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 2,800 | $108.38 | $303,464.00 | 3,500 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 1,800 | $109.30 | $196,740.00 | 1,700 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 1,000 | $110.64 | $110,640.00 | 700 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 700 | $111.41 | $77,987.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 10, 2026 | Exercise/Conversion | 1,250 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 10, 2026 | Exercise/Conversion | 6,500 | $0.00 | $0.00 | 0 | Direct | โ | View Details |